CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement
Open accessThe DOI matches its Crossref record; 286 of the 286 references it cites were found in a registry or an index.
Abstract
Since it was first recognized in bacteria and archaea as a mechanism for innate viral immunity in the early 2010s, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) has rapidly been developed into a robust, multifunctional genome editing tool with many uses. Following the discovery of the initial CRISPR/Cas-based system, the technology has been advanced to facilitate a multitude of different functions. These include development as a base editor, prime editor, epigenetic editor, and CRISPR interference (CRISPRi) and CRISPR activator (CRISPRa) gene regulators. It can also be used for chromatin and RNA targeting and imaging. Its applications have proved revolutionary across numerous biological fields, especially in biomedical and agricultural improvement. As a diagnostic tool, CRISPR has been developed to aid the detection and screening of both human and plant diseases, and has even been applied during the current coronavirus disease 2019 (COVID-19) pandemic. CRISPR/Cas is also being trialed as a new form of gene therapy for treating various human diseases, including cancers, and has aided drug development. In terms of agricultural breeding, precise targeting of biological pathways via CRISPR/Cas has been key to regulating molecular biosynthesis and allowing modification of proteins, starch, oil, and other functional components for crop improvement. Adding to this, CRISPR/Cas has been shown capable of significantly enhancing both plant tolerance to environmental stresses and overall crop yield via the targeting of various agronomically important gene regulators. Looking to the future, increasing the efficiency and precision of CRISPR/Cas delivery systems and limiting off-target activity are two major challenges for wider application of the technology. This review provides an in-depth overview of current CRISPR development, including the advantages and disadvantages of the technology, recent applications, and future considerations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–286 of 286
Repurposing CRISPR/Cas9 for in situ functional assays
Malina, A., Mills, J. R., Cencic, R., Yan, Y., Fraser, J., Schippers, L. M., Paquet, M., Dostie, J., & Pelletier, J. (2013) · Genes & Development · doi:10.1101/gad.227132.113 · Cited by 133 · cited 1×
“By using an all-in-one lentiviral and retroviral delivery vectors hosting both Cas9 and sgRNAs, Malina et al. (2013) showed robust selection for the CRISPR-modified Trp53 locus following drug treatment.”
BackgroundHighly specific targeted mutagenesis in plants using Staphylococcus aureus Cas9
Kaya, H., Mikami, M., Endo, A., Endo, M., & Toki, S. (2016) · Scientific Reports · doi:10.1038/srep26871 · Cited by 132 · cited 2×
“, 2015), and it has recently been shown to have high editing efficiency in mammalian and plant cells (Ran et al., 2015; Steinert et al., 2015; Kaya et al., 2016; Xie HH et al., 2020).”
BackgroundHuo, W., Zhao, G., Yin, J., Ouyang, X., Wang, Y., Yang, C., Wang, B., Dong, P., Wang, Z., Watari, H., et al. (2016) · Journal of Cancer · doi:10.7150/jca.16723 · Cited by 126 · cited 6×
“The edited cell lines revealed that the miR21 knock-out significantly inhibited cancer cell proliferation, migration, and invasion, highlighting a prime target for cancer gene therapies (Huo et al., 2017).”
BackgroundInfluentialBaker, M. (2011) · Nature Methods · doi:10.1038/nmeth.1807 · Cited by 123 · cited 1×
“However, ZFNs recognize C2–H2 domains, whereas TALENs recognize DNA through transcription activator-like effectors (TALEs) (Baker, 2012).”
BackgroundDevelopment of CRISPR/Cas9 system in Chlorella vulgaris FSP-E to enhance lipid accumulation
Lin, W.-R., & Ng, I.-S. (2020) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2019.109458 · Cited by 121 · cited 1×
“For example, Lin and Ng (2020) used CIRSPR/Cas9 to knock out the fad3 gene and obtained a 46% higher accumulation of lipids in Chlorella vulgaris FSP-E.”
MethodExpanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice
Li, S., Zhang, X., Wang, W., Guo, X., Wu, Z., Du, W., Zhao, Y., & Xia, L. (2018) · Molecular Plant · doi:10.1016/j.molp.2018.03.009 · Cited by 120 · cited 2×
“By targeting genes associated with GABA metabolism, including GABA‐TP1, GABA‐TP2, GABA‐TP3, CAT9, and SSADH, Li et al. (2018b) obtained CRISPR genome-edited tomatoes with GABA content up to 19-fold higher than that of the wild type.”
BackgroundElevating seed oil content in a polyploid crop by induced mutations in SEED FATTY ACID REDUCER genes
Karunarathna, N. L., Wang, H., Harloff, H., Jiang, L., & Jung, C. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13381 · Cited by 119 · cited 1×
“…et al., 2019 Ozseyhan et al., 2018 Aznar-Moreno and Durrett, 2017 Lyzenga et al., 2019 Zhang et al., 2019 Zhai et al., 2020 Sashidhar et al., 2020 Karunarathna et al., 2020 Xie T et al., 2020 Zhang Y et al., 2018 Ren et al., 2016 Nakayasu et al., 2018 Liang et al., 2014 Zhu et al.,…”
BackgroundCRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology
Tian, X., Gu, T., Patel, S., Bode, A. M., Lee, M., & Dong, Z. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0080-7 · Cited by 119 · cited 1×
“CRISPR/Cas-based therapeutic tools can also be used to diagnose non-infectious diseases, including cancers and genetic disorders (Tian et al., 2019).”
BackgroundTravis, J. P. (2015) · Science · doi:10.1126/science.350.6267.1456 · Cited by 114
van den Broeck, H. C., van Herpen, T. W. J. M., Schuit, C., Salentijn, E. M. J., Dekking, L., Bosch, D., Hamer, R. J., SMULDERS, M. J. M., Gilissen, L. J. W. J., & Meer, I. M. V. D. (2009) · BMC Plant Biology · doi:10.1186/1471-2229-9-41 · Cited by 114 · cited 1×
“In breeding programs, scientists and breeders have used traditional breeding technology and mutation breeding (e.g., chemically or physically induced amastigogenesis) to obtain low-gluten-content cultivars (van den Broeck et al., 2009; Juhász et al., 2020).”
BackgroundPark, J., Yoo, C. G., Flanagan, A., Pu, Y., Debnath, S., Ge, Y., Ragauskas, A. J., & Wang, Z. (2017) · Biotechnology for Biofuels · doi:10.1186/s13068-017-0972-0 · Cited by 114 · cited 1×
“…et al., 2015 Li et al., 2017 Jiang et al., 2013 Wang HX et al., 2019 Wang et al., 2015 Ron et al., 2014 Syombua et al., 2020 Odipio et al., 2017 Park et al., 2017 Liu Y et al., 2018 Braatz et al., 2017 Cai et al., 2018 Nishitani et al., 2016 Jia and Wang, 2014 Charrier et al., 2019 Zhou et…”
Su, S., Zou, Z., Chen, F., Ding, N., Du, J., Shao, J., Li, L., Fu, Y. S., Hu, B., Yang, Y., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1249558 · Cited by 112
Simultaneous Targeting of Multiple Gene Homeologs to Alter Seed Oil Production in Camelina sativa
Aznar‐Moreno, J. A., & Durrett, T. P. (2017) · Plant and Cell Physiology · doi:10.1093/pcp/pcx058 · Cited by 112 · cited 1×
“…al., 2018 Yuan et al., 2019 Huang et al., 2020 Okuzaki et al., 2018 Tian et al., 2020 Chen YZ et al., 2021 al Amin et al., 2019 Ozseyhan et al., 2018 Aznar-Moreno and Durrett, 2017 Lyzenga et al., 2019 Zhang et al., 2019 Zhai et al., 2020 Sashidhar et al., 2020 Karunarathna et al., 2020 Xie T et…”
BackgroundCleavage of Phage DNA by the Streptococcus thermophilus CRISPR3-Cas System
Magadán, A. H., Dupuis, M.-È., Villion, M., & Moineau, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040913 · Cited by 110 · cited 8×
“…recog‐ nizes a 5'-N4GATT-3' PAM (Esvelt et al., 2013; Hou et al., 2013), whereas St1Cas9 and St3Cas9, derived from Streptococcus thermophilus, both require either 5'- NNAGAAW-3' (where W represents A or T) or 5'- NGGNG-3' PAMs (Garneau et al., 2010; Magadán et al., 2012; Müller et al., 2016).”
BackgroundInfluentialSimplified adenine base editors improve adenine base editing efficiency in rice
Hua, K., Tao, X., Liang, W., Zhang, Z., Gou, R., & Zhu, J. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13244 · Cited by 108 · cited 1×
“This converts an A to a G, initiating an A/T to G/C base pair switch (Gaudelli et al., 2017; Kang et al., 2018; Hua et al., 2020).”
BackgroundSashidhar, N., Harloff, H. J., Potgieter, L., & Jung, C. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13380 · Cited by 108 · cited 1×
“…YZ et al., 2021 al Amin et al., 2019 Ozseyhan et al., 2018 Aznar-Moreno and Durrett, 2017 Lyzenga et al., 2019 Zhang et al., 2019 Zhai et al., 2020 Sashidhar et al., 2020 Karunarathna et al., 2020 Xie T et al., 2020 Zhang Y et al., 2018 Ren et al., 2016 Nakayasu et al., 2018 Liang et al.,…”
BackgroundIncreasing the efficiency of CRISPR‐Cas9‐VQR precise genome editing in rice
Hu, X., Meng, X., Liu, Q., Li, J., & Wang, K. (2017) · Plant Biotechnology Journal · doi:10.1111/pbi.12771 · Cited by 107
Kanitchinda, S., Srisala, J., Suebsing, R., Prachumwat, A., & Chaijarasphong, T. (2020) · Biotechnology Reports · doi:10.1016/j.btre.2020.e00485 · Cited by 105
Silencing of γ-gliadins by RNA interference (RNAi) in bread wheat
Gil‐Humanes, J., Pistón, F., Hernando, A., Álvarez, J. B., Shewry, P. R., & Barro, F. (2008) · Journal of Cereal Science · doi:10.1016/j.jcs.2008.03.005 · Cited by 103 · cited 1×
“…tech‐ nology, by targeting a specific gene during gluten bio‐ synthesis, several different laboratories have knocked down an individual gene and obtained RNAi plants with a reduced gluten content (Gil-Humanes et al., 2008, 2010; Becker et al., 2012; Barro et al., 2016; Alten‐ bach et al., 2019).”
BackgroundZhang, K., Nie, L., Cheng, Q., Yin, Y., Chen, K., Qi, F., Zou, D., Liu, H., Zhao, W., Wang, B., et al. (2019) · Biotechnology for Biofuels · doi:10.1186/s13068-019-1567-8 · Cited by 100 · cited 1×
“…et al., 2018 Tian et al., 2020 Chen YZ et al., 2021 al Amin et al., 2019 Ozseyhan et al., 2018 Aznar-Moreno and Durrett, 2017 Lyzenga et al., 2019 Zhang et al., 2019 Zhai et al., 2020 Sashidhar et al., 2020 Karunarathna et al., 2020 Xie T et al., 2020 Zhang Y et al., 2018 Ren et al., 2016…”
BackgroundCRISPR /Cas9‐mediated functional recovery of the recessive rc allele to develop red rice
Zhu, Y., Lin, Y., Chen, S., Liu, H., Chen, Z., Fan, M., Hu, T., Mei, F., Chen, J., Chen, L., et al. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13125 · Cited by 99 · cited 4×
“(2019) used CRISPR/Cas9 genome editing technology to success‐ fully restore the function of the Rc gene by reverting the 14-bp frame-shift deletion to in-frame mutations (Zhu et al., 2019).”
BackgroundMethodInfluentialDeng, H., Tan, S., Gao, X., Zou, C., Xu, C., Tu, K., Song, Q., Fan, F., Huang, W., & Zhang, Z. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.004 · Cited by 98 · cited 2×
“CRISPR/Cas9 knock-out of the cdk5 gene blocked the expression of the PD-L1 gene and enhanced cell antitumor immunity (Yahata et al., 2019; Deng et al., 2020).”
BackgroundShin, J. J., Schröder, M., Caiado, F., Wyman, S. K., Bray, N., Bordi, M., DeWitt, M. A., Vu, J. T., Kim, W., Hockemeyer, D. F., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108093 · Cited by 95 · cited 1×
“Meganucleases are a class of en‐ dodeoxyribonucleases, which occur naturally in a variety of different organisms (Silva et al., 2011).”
BackgroundNext-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy
Zeballos C., M. A., & Gaj, T. (2021) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.10.010 · Cited by 94 · cited 2×
“CRISPR/Cas has been developed as a powerful and promising tool for gene therapy (Lotfi and Rezaei, 2020; Zeballos and Gaj, 2020; Ferrari et al., 2021; Zhang, 2021).”
MethodInfluentialSun, B., Jiang, M., Zheng, H., Jian, Y., Huang, W., Yuan, Q., Zheng, A., Chen, Q., Zhang, Y., Lin, Y., et al. (2020) · Horticulture Research · doi:10.1038/s41438-020-00379-w · Cited by 91 · cited 1×
“Sun et al. (2019) devel‐ oped a drug-inducible CRISPR/Cas9 system that can be used both in vitro and in vivo for large-scale func‐ tional screening of human diseases.”
BackgroundProgress and Challenges for Live-Cell Imaging of Genomic Loci using CRISPR-Based Platforms
Wu, X., Mao, S., Ying, Y., Krueger, C. J., & Chen, A. K. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.10.001 · Cited by 90
Barro, F., Iehisa, J. C. M., Giménez, M. J., García-Molina, M. D., Ozuna, C. V., Comino, I., Sousa, C., & Gil‐Humanes, J. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12455 · Cited by 88 · cited 2×
“…tech‐ nology, by targeting a specific gene during gluten bio‐ synthesis, several different laboratories have knocked down an individual gene and obtained RNAi plants with a reduced gluten content (Gil-Humanes et al., 2008, 2010; Becker et al., 2012; Barro et al., 2016; Alten‐ bach et al., 2019).”
BackgroundPröbsting, M., Schenke, D., Hossain, R., Häder, C., Thurau, T., Wighardt, L., Schuster, A., Zhou, Z. J., Ye, W., Rietz, S., et al. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13394 · Cited by 88 · cited 1×
“…to Verticillium longisporum in both 265 | J Zhejiang Univ-Sci B (Biomed & Biotechnol) 2021 22(4):253-284 Arabidopsis thaliana and oilseed rape (Pröbsting et al., 2020), OsERF922 for resistance to Magnaporthe oryzae in rice (Wang et al., 2016), Clpsk1 for resistance to Fusarium oxysporum f.…”
BackgroundxC as9 expands the scope of genome editing with reduced efficiency in rice
Wang, J., Meng, X., Hu, X., Sun, T., Li, J., Wang, K., & Yu, H. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13053 · Cited by 87
Increased lateral root formation by CRISPR/Cas9-mediated editing of arginase genes in cotton
Wang, Y., Meng, Z., Liang, C., Meng, Z., Wang, Y., Sun, G., Zhu, Τ., Cai, Y., Guo, S., Zhang, R., et al. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9031-y · Cited by 86 · cited 1×
“Using CRISPR/Cas9 genome editing technology, Wang et al. (2017) successfully knocked out the arg gene in cotton.”
MethodCui, Y., Jiang, N., Xu, Z., & Xu, Q. (2020) · BMC Plant Biology · doi:10.1186/s12870-020-2289-6 · Cited by 86 · cited 1×
“Under salinity treatment, all tested genome-edited lines showed enhanced tolerance compared to the controls (Cui et al., 2020).”
BackgroundEllis, B. L., Hirsch, M. L., Porter, S. N., Samulski, R. J., & Porteus, M. H. (2013) · Gene Therapy · doi:10.1038/gt.2011.211 · Cited by 84 · cited 1×
“Al‐ though both ZFNs and TALENs have been well used to target and edit specific genes, with some applica‐ tions in clinical treatments (Ellis et al., 2013; Xu et al., 2014; Aravalli and Steer, 2016; Bañuls et al., 2020), they both have some shortcomings for genome editing.”
BackgroundCRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics
Kumar, P., Malik, Y. S., Ganesh, B., Rahangdale, S., Saurabh, S., Natesan, S. K. A., Srivastava, A., Sharun, K., Yatoo, M. I., Tiwari, R., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.576875 · Cited by 83 · cited 3×
“However, CRISPR/Cas-based diagnostic tools may have advan‐ tages for detecting different pathogens, including the SARS-CoV-2 virus, due to their higher sensitivity and specificity compared to traditional PCR and realtime quantitative reverse transcription-PCR (qRTPCR) (Kumar et al., 2020).”
BackgroundMethodTargeted mutagenesis in tetraploid switchgrass (Panicum virgatum L.) using CRISPR/Cas9
Liu, Y., Merrick, P., Zhang, Z., Ji, C., Yang, B., & Fei, S. (2017) · Plant Biotechnology Journal · doi:10.1111/pbi.12778 · Cited by 82
Liu, Y., Qi, X., Zeng, Z., Wang, L., Wang, J., Zhang, T., Xu, Q., Shen, C., Zhou, G., Yang, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03070-8 · Cited by 78 · cited 3×
“These include mouse, rat, pig, and rabbit models for studying various human diseases, including human non‐small‐cell lung cancers (NSCLCs) (Maddalo et al., 2014), hepatocellular carcinoma (HCC) (Liu et al., 2017), Hutchinson-Gilford progeria syndrome (HGPS) (Liu ZQ et al., 2018), corneal dystrophy (Kitamoto et al., 20…”
BackgroundInfluential(2011) · Nature Methods · doi:10.1038/nmeth.1852 · Cited by 77
In vivo locus-specific editing of the neuroepigenome
Yim, Y. Y., Teague, C. D., & Nestler, E. J. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0334-y · Cited by 76 · cited 1×
“CRISPR/Cas technology has also been adapted for use in live cell chromatin imaging (Ma et al., 2015; Fu et al., 2016; Wu XT et al., 2019; Khosravi et al., 2020) and manipulation of chro‐ matin topology (Adli, 2018; Yim et al., 2020).”
MethodExpanding the genome-targeting scope and the site selectivity of high-precision base editors
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2020) · Nature Communications · doi:10.1038/s41467-020-14465-z · Cited by 75
Evaluation of sgRNA Target Sites for CRISPR-Mediated Repression of TP53
Lawhorn, I. E. B., Ferreira, J. P., & Wang, C. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113232 · Cited by 75 · cited 1×
“The efficiency of CRISPRi strongly depended on sgRNA quality and target site efficiency, although it was shown that targeting any part of a gene, including the promoter, transcript sequence, and even UTR regions, could pro‐ vide up to 86% repression with dCas9 alone (Lawhorn et al., 2014).”
BackgroundLyzenga, W. J., Harrington, M., Bekkaoui, D., Wigness, M., Hegedus, D. D., & Rozwadowski, K. L. (2019) · BMC Plant Biology · doi:10.1186/s12870-019-1873-0 · Cited by 74 · cited 1×
“…et al., 2020 Okuzaki et al., 2018 Tian et al., 2020 Chen YZ et al., 2021 al Amin et al., 2019 Ozseyhan et al., 2018 Aznar-Moreno and Durrett, 2017 Lyzenga et al., 2019 Zhang et al., 2019 Zhai et al., 2020 Sashidhar et al., 2020 Karunarathna et al., 2020 Xie T et al., 2020 Zhang Y et al.,…”
BackgroundCRISPR-based assays for rapid detection of SARS-CoV-2
Javalkote, V. S., Kancharla, N., Bhadra, B., Shukla, M. R., Soni, B., Sapre, A. V., Goodin, M. M., Bandyopadhyay, A., & Dasgupta, S. (2020) · Methods · doi:10.1016/j.ymeth.2020.10.003 · Cited by 73 · cited 1×
“There have been several reports on diagnos‐ tics and detection of SARS-CoV-2 using CRISPR/ Cas-based therapeutic tools (Chen et al., 2018; Ali et al., 2020; Broughton et al., 2020; Ding et al., 2020; Islam and Iqbal, 2020; Javalkote et al., 2020; Wang M et al., 2020; Wang XJ et al., 2020b).”
CRISPR/Cas13: A potential therapeutic option of COVID-19
Lotfi, M., & Rezaei, N. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110738 · Cited by 72 · cited 2×
“CRISPR/Cas has been developed as a powerful and promising tool for gene therapy (Lotfi and Rezaei, 2020; Zeballos and Gaj, 2020; Ferrari et al., 2021; Zhang, 2021).”
MethodInfluentialLi, C., Zhang, L., Fu, Q., & Xu, Z. (2018) · PeerJ · doi:10.7717/peerj.4812 · Cited by 70 · cited 1×
“…HX et al., 2019 Wang et al., 2015 Ron et al., 2014 Syombua et al., 2020 Odipio et al., 2017 Park et al., 2017 Liu Y et al., 2018 Braatz et al., 2017 Cai et al., 2018 Nishitani et al., 2016 Jia and Wang, 2014 Charrier et al., 2019 Zhou et al., 2015 Navet and Tian, 2020 * There are many reports…”
BackgroundSelf-citationBrandsma, E. T., Verhagen, H. J. M. P., van de Laar, T. J. W., Claas, E. C. J., Cornelissen, M. T. E., & van den Akker, E. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa641 · Cited by 67
Successful generation of epigenetic disease model mice by targeted demethylation of the epigenome
Horii, T., Morita, S., Hino, S., Kimura, M., Hino, Y., Kogo, H., Nakao, M., & Hatada, I. (2020) · Genome biology · doi:10.1186/s13059-020-01991-8 · Cited by 64 · cited 2×
“Several studies have shown CRISPR/dCas9TET1 capable of removing up to 90% of targeted meth‐ ylations, significantly increasing gene expression at the target sites (Liu et al., 2016; Morita et al., 2016; Han‐ zawa et al., 2020; Horii et al., 2020).”
BackgroundMethodHigh-fidelity SaCas9 identified by directional screening in human cells
Xie, H., Ge, X., Yang, F., Wang, B., Li, S., Duan, J., Lv, X., Cheng, C., Song, Z., Liu, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000747 · Cited by 63
Engineering Smut Resistance in Maize by Site-Directed Mutagenesis of LIPOXYGENASE 3
Pathi, K. M., Rink, P., Budhagatapalli, N., Betz, R., Saado, I., Hiekel, S., Becker, M. A., Djamei, A., & Kumlehn, J. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.543895 · Cited by 63 · cited 2×
“, 2019), and LIPOXYGENASE 3 (lox3) for resistance to Ustilago maydis in maize (Pathi et al., 2020).”
BackgroundFrom Sequencing to Genome Editing for Cotton Improvement
Peng, R., Jones, D. C., Liu, F., & Zhang, B. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.09.001 · Cited by 61 · cited 2×
“However, after many years of hard work, this problem was solved in rice and maize, mainly by selecting immature embryos as explants (Peng et al., 2021).”
BackgroundSelf-citationGe, Z., Zheng, L., Zhao, Y., Jiang, J., Zhang, E. J., Liu, T., Gu, H., & Qu, L. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13148 · Cited by 61 · cited 23×
“In recognition of this, CRISPR/Cas was selected by Sci‐ ence as the 2015 Breakthrough of the Year (Travis, Table 1 Comparison of major genome editing tools Genome editing tool Meganucleases ZFN TALEN CRISPR/Cas Genome editing tool Meganucleases ZFN TALEN CRISPR/Cas Interaction Protein‒DNA Protein‒DNA Protein‒DNA RNA‒D…”
BackgroundInfluentialMultiple gene substitution by Target-AID base-editing technology in tomato
Hunziker, J., Nishida, K., Kondo, A., Kishimoto, S., Ariizumi, T., & Ezura, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-77379-2 · Cited by 61 · cited 1×
“…CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 (NHEJ and HDR) CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 Reference Hunziker et al., 2020 Li XD et al., 2018 Zsögön et al., 2018 Li TD et al., 2018 Kaur et al., 2020 Sun et al., 2020 Yang et al., 2017 Yu et al.,…”
Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening
Sun, N., Petiwala, S. M., Wang, R., Lu, C., Hu, M., Ghosh, S., Hao, Y., Miller, C. P., & Chung, N. (2019) · BMC Genomics · doi:10.1186/s12864-019-5601-9 · Cited by 58 · cited 2×
“…CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 CRISPR/Cas9 Reference Li JY et al., 2020 Sun et al., 2017 Zhang JS et al., 2018 Andersson et al., 2018 Kusano et al., 2018 Sánchez-León et al., 2018 Jouanin et al., 2019 Jiang et al.,…”
BackgroundInfluentialIn vivo epigenome editing and transcriptional modulation using CRISPR technology
Lau, C., & Suh, Y. (2018) · Transgenic Research · doi:10.1007/s11248-018-0096-8 · Cited by 57 · cited 3×
“Lau and Suh (2018) successfully demonstrated this by targeting a CGG expansion mutation in the 5'-untranslated region (5'-UTR) of the fragile X mental retardation 1 (FMR1) gene in Fragile X syndrome (FXS) patients, which is the most common form of genetic intellectual disability in males.”
BackgroundMethodYahata, T., Mizoguchi, M., Kimura, A., Orimo, T., Toujima, S., Kuninaka, Y., Nosaka, M., Ishida, Y., Sasaki, I., Fukuda‐Ohta, Y., et al. (2019) · Cancer Science · doi:10.1111/cas.13958 · Cited by 57 · cited 2×
“…of PD-L1/PD-1 may also be beneficial for treating other cancers, including Epstein-Barr virus (EBV)-positive gastric cancer (Su et al., 2017), melanoma (Mahoney et al., 2015), glioblastoma (Choi et al., 2019), colorectal cancer (Liao et al., 2020), and ovarian cancers (Yahata et al., 2019).”
BackgroundBecker, D., Wieser, H., Koehler, P., Folck, A. J., Mühling, K. H., & Zörb, C. (2012) · Angewandte Botanik · doi:10.5073/jabfq.2012.085.004 · Cited by 55
Altenbach, S. B., Chang, H.-C., Yu, X. B., Seabourn, B. W., Green, P. H., & Alaedini, A. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00580 · Cited by 54
CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy
Soares, F., Chen, B., Lee, J. B., Ahmed, M., Ly, D., Tin, E., Kang, H., Zeng, Y., Akhtar, N., Minden, M. D., et al. (2020) · Blood · doi:10.1182/blood.2019004108 · Cited by 53
Tian, Y., Chen, K., Li, X., Zheng, Y., & Chen, F. (2020) · BMC Plant Biology · doi:10.1186/s12870-020-02441-0 · Cited by 52 · cited 4×
“In tobacco, CRISPR/Cas9 knockout of the fad2 gene dramatically increased the oleic acid content from 11% to ˃79%, whereas linoleic acid was reduced from 72% to 7% (Tian et al., 2020).”
BackgroundInfluentialHe, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00283-8 · Cited by 46 · cited 1×
“Their re‐ sults showed that the CRISPR/Cas-edited donor cells persisted for more than 19 months after transplantation without causing gene-editing-related adverse events (Xu et al., 2019; He, 2020).”
BackgroundYang, X., Chen, L., He, J., & Yu, W. (2017) · Plant Cell Reports · doi:10.1007/s00299-017-2172-6 · Cited by 46 · cited 1×
“…CRISPR/Cas9 CRISPR/Cas9 Reference Hunziker et al., 2020 Li XD et al., 2018 Zsögön et al., 2018 Li TD et al., 2018 Kaur et al., 2020 Sun et al., 2020 Yang et al., 2017 Yu et al., 2017 Li R et al., 2018a Ito et al., 2015 Jung et al., 2018 CRISPR: clustered regularly interspaced short palindromic…”
BackgroundGeneration and Application of the Zebrafish heg1 Mutant as a Cardiovascular Disease Model
Lu, S., Hu, M., Wang, Z., Liu, H., Kou, Y., Lyu, Z., & Tian, J. (2020) · Biomolecules · doi:10.3390/biom10111542 · Cited by 46
LSD1 Histone Demethylase Assays and Inhibition
Hayward, D., & Cole, P. A. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.01.020 · Cited by 45
Wu, M., Liu, H., Lin, Y., Chen, J., Fù, Y., JiaMi, L., Zhang, Z., Liang, K., Chen, S., & Wang, F. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00307 · Cited by 44 · cited 5×
“By targeting the fad2 gene using CRISPR/Cas9, Jiang et al. (2017) obtained CRISPR/ Cas genome-edited Camelina sativa plants with oleic acid content increased from 16% to ˃50% of the fatty acid composition (Jiang et al., 2017).”
BackgroundInfluentialFeng, Y.-L., Liu, S., Chen, R.-D., & Xie, A. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000282 · Cited by 44 · cited 1×
“Although both NHEJ and HDR can be used to repair DSBs generated by CRISPR/Cas, NHEJ is the most common (Feng et al., 2021).”
Liao, T., Lin, C., Jiang, J., Yang, S.-H., Teng, H., & Yang, M. (2020) · Theranostics · doi:10.7150/thno.44147 · Cited by 43 · cited 2×
“…of PD-L1/PD-1 may also be beneficial for treating other cancers, including Epstein-Barr virus (EBV)-positive gastric cancer (Su et al., 2017), melanoma (Mahoney et al., 2015), glioblastoma (Choi et al., 2019), colorectal cancer (Liao et al., 2020), and ovarian cancers (Yahata et al., 2019).”
BackgroundDu, J., Duan, S., Wang, H., Chen, W., Zhao, X., Zhang, A., Wang, L., Xuan, J., Yu, L., Wu, S., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0844-z · Cited by 41 · cited 4×
“This work was supported by the National Natural Science Foundation of China (No. 31700316), the Fundamental Research Funds for the Central Nonprofit Scientific Institution (No. 1610172018009), and the Natural Science Foundation of Hubei Province (No. 2018CFB543), China.”
BackgroundInfluentialWu, Y., Xu, W., Wang, F., Zhao, S., Feng, F., Song, J., Zhang, C., & Yang, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00379 · Cited by 40
Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing
Hanzawa, N., Hashimoto, K., Yuan, X., Kawahori, K., Tsujimoto, K., Hamaguchi, M., Tanaka, T., Nagaoka, Y., Nishina, H., Morita, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62035-6 · Cited by 39
Efficient targeted mutagenesis in allotetraploid sweet basil by CRISPR/Cas9
Navet, N., & Tian, M. (2020) · Plant Direct · doi:10.1002/pld3.233 · Cited by 38 · cited 1×
“…et al., 2020 Odipio et al., 2017 Park et al., 2017 Liu Y et al., 2018 Braatz et al., 2017 Cai et al., 2018 Nishitani et al., 2016 Jia and Wang, 2014 Charrier et al., 2019 Zhou et al., 2015 Navet and Tian, 2020 * There are many reports on different plant species for CRISPR/Cas-based genome editing.”
BackgroundMeng, Z., Meng, Z., Zhang, R., Liang, C., Wan, J., Wang, Y., Zhai, H., & Guo, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141530 · Cited by 35 · cited 1×
“In contrast, overexpression of the arg gene in‐ hibited NO accumulation and further repressed lateral root development in transgenic cotton (Meng et al., 2015).”
BackgroundDNA repair protein RAD51 enhances the CRISPR/Cas9-mediated knock-in efficiency in brain neurons
Kurihara, T., Kouyama-Suzuki, E., Satoga, M., Li, X., Badawi, M., Thiha, Baig, D. N., Yanagawa, T., Uemura, T., Mori, T., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.132 · Cited by 35 · cited 2×
“Co-transfection of a CRISPR/Cas system with RAD51, a key molecule during the initial step of HDR, also increased HDR efficiency 2.5-fold in layers 2/3 of pyramidal neurons in the somatosensory cortex of mouse brains (Kurihara et al., 2020).”
BackgroundInfluentialGene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?
Bañuls, L., Pellicer, D., Castillo, S., Navarro‐García, M. M., Magallón, M., González, C., & Dasí, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082577 · Cited by 35 · cited 1×
“Al‐ though both ZFNs and TALENs have been well used to target and edit specific genes, with some applica‐ tions in clinical treatments (Ellis et al., 2013; Xu et al., 2014; Aravalli and Steer, 2016; Bañuls et al., 2020), they both have some shortcomings for genome editing.”
BackgroundBungsy, M., Palmer, M. C. L., Jeusset, L. M., Neudorf, N. M., Lichtensztejn, Z., Nachtigal, M. W., & McManus, K. J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.051 · Cited by 34 · cited 2×
“Using CRISPR/ Cas9 genome editing, Bungsy et al. (2021) showed that the expression of RBX1 was associated with chro‐ mosome instability (CIN).”
BackgroundVirus-Based CRISPR/Cas9 Genome Editing in Plants
Liu, H., & Zhang, B. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.08.002 · Cited by 33 · cited 1×
“Further modifications of this virus-based CRISPR/Cas reagent delivery system will provide a tissue culture-independent transgenic and genome editing system that can be used for any plant species without the need for a complicated laboratory process (Liu and Zhang, 2020).”
BackgroundSelf-citationFujihara, K., Yamada, K., Ichitani, Y., Kakizaki, T., Jiang, W., Miyata, S., Suto, T., Kato, D., Saito, S., Watanabe, M., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01108-6 · Cited by 33 · cited 2×
“Genetic evidence has shown that GABAergic dysfunction is associated with the patho‐ genesis of schizophrenia, and the γ -aminobutyric acid (GABA) synthetic enzyme glutamate decarboxylase 67-kDa isoform (GAD67) is downregulated in the brains of patients with the disease (Fujihara et al., 2020).”
BackgroundA CRISPR-Cas9 repressor for epigenetic silencing of KRAS
Liu, J., Sun, M., Cho, K. B., Gao, X., & Guo, B. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105304 · Cited by 30 · cited 1×
“With the KRAS mutation, cell growth was significantly inhibited and the cell death was increased in cancer cells (Liu et al., 2021).”
BackgroundKitamoto, K., Taketani, Y., Fujii, W., Inamochi, A., Toyono, T., Miyai, T., Yamagami, S., Kuroda, M., Usui, T., & Ouchi, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-58876-w · Cited by 29 · cited 2×
“…human non‐small‐cell lung cancers (NSCLCs) (Maddalo et al., 2014), hepatocellular carcinoma (HCC) (Liu et al., 2017), Hutchinson-Gilford progeria syndrome (HGPS) (Liu ZQ et al., 2018), corneal dystrophy (Kitamoto et al., 2020), and X-linked dilated cardiomyopathy (XLCM) (Liu ZQ et al., 2018).”
BackgroundLiu, Y., Wang, W., Yang, B., Currey, C. J., & Fei, S. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.572193 · Cited by 28 · cited 2×
“In the biofuel crop switchgrass, CRISPR/Cas9 knock-out of the teosinte branched 1 (tb1) gene in‐ creased the number of plant tillers and fresh biomass (Liu et al., 2020).”
BackgroundGene editing: an instrument for practical application of gene biology to plant breeding
Tan, Y., Du, H., Wu, X., Liu, Y., Jiang, M., Song, S., Wu, L., & Shu, Q. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900633 · Cited by 26
Gene editing technology as an approach to the treatment of liver diseases
Aravalli, R. N., & Steer, C. J. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1158808 · Cited by 24 · cited 1×
“Al‐ though both ZFNs and TALENs have been well used to target and edit specific genes, with some applica‐ tions in clinical treatments (Ellis et al., 2013; Xu et al., 2014; Aravalli and Steer, 2016; Bañuls et al., 2020), they both have some shortcomings for genome editing.”
BackgroundAKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling
Gao, S. P., Kiliti, A. J., Zhang, K., Vasani, N. B., Mao, N., Jordan, E., Wise, H. C., Shrestha-Bhattarai, T., Hu, W., Dorso, M. A., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0623 · Cited by 24 · cited 2×
“Gao et al. (2021) used CRISPR/Cas genome editing to study the biological role of the AKT1 E17K mutation in a TP53-null background.”
BackgroundMethodSpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power
Zhang, D., & Zhang, B. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.05.001 · Cited by 23 · cited 2×
“If we can fuse a proofreading enzyme, like DNA polymerase, with the Cas enzyme, when an off-target event occurs, the proof‐ reading enzyme will correct any errors (Zhang and Zhang, 2020b).”
BackgroundSelf-citationJiang, F., Liang, Y., Wei, W., Zou, C., Chen, G., Wan, Y., Liu, Z., Yang, Y., Han, Z., Zhu, J., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11491 · Cited by 23 · cited 5×
“By targeting the fad2 gene using CRISPR/Cas9, Jiang et al. (2017) obtained CRISPR/ Cas genome-edited Camelina sativa plants with oleic acid content increased from 16% to ˃50% of the fatty acid composition (Jiang et al., 2017).”
BackgroundInfluentialHigh-quality sugar production by osgcs1 rice
Honma, Y., Adhikari, P. B., Kuwata, K., Kagenishi, T., Yokawa, K., Notaguchi, M., Kurotani, K., Toda, E., Bessho‐Uehara, K., Liu, X., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01329-x · Cited by 22 · cited 2×
“Recently, Honma et al. (2020) knocked out the OsGcs1 gene in rice by CRISPR/Cas and obtained sugary-rice grains containing a high percentage of high-quality sugar.”
BackgroundKhosravi, S., Ishii, T., Dreißig, S., & Houben, A. (2019) · Chromosome Research · doi:10.1007/s10577-019-09622-0 · Cited by 20 · cited 1×
“CRISPR/Cas technology has also been adapted for use in live cell chromatin imaging (Ma et al., 2015; Fu et al., 2016; Wu XT et al., 2019; Khosravi et al., 2020) and manipulation of chro‐ matin topology (Adli, 2018; Yim et al., 2020).”
MethodJin, Y. O., Datsomor, A. K., Olsen, R. E., Vik, J. O., Torgersen, J. S., Edvardsen, R. B., Wargelius, A., Winge, P., & Grammes, F. (2020) · BMC Genomics · doi:10.1186/s12864-020-07218-1 · Cited by 12 · cited 1×
“CRISPR/Cas9 knock-out of the fad2 gene in Atlantic salmon also altered their lipid metabolism (Jin et al., 2020).”
BackgroundCao, X., Kouyama-Suzuki, E., Pang, B., Kurihara, T., Mori, T., Yanagawa, T., Shirai, Y., & Tabuchi, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.053 · Cited by 12 · cited 2×
“Inhibition of DNA ligase IV (LIG4), an essential molecule for NHEJ, increased efficiency of HDR-mediated knock-in (Cao et al., 2020).”
Background
Cited by
Tariq, A., Mushtaq, M., Yaqoob, H., Bhat, B. A., Zargar, S. M., Raza, A., Ali, S., Charagh, S., Mubarik, M. S., Zaman, Q. U., et al. (2023) · GM Crops & Food · doi:10.1080/21645698.2023.2219111 · Cited by 45
“In recent years, the advancements and developments in engineered CRISPR-Cas9 system has revolutionized targeted GE in plants and animals as it can recognize the target sites only via a singleguide RNA (sgRNA), unlike ZFN and TALEN.(37,38) With the introduction of the CRISPR-toolbox, scientists are now better able to c…”
Background
Metadata
- Authors
- Li, C., Brant, E., Budak, H., & Zhang, B.
- Venue
- Journal of Zhejiang University-SCIENCE B
- Publisher
- Zhejiang University Press
- Published
- 2021-04
- Volume
- 22
- Issue
- 4
- Pages
- 253-284
- ISSN
- 1673-1581 (ISSN-L)
- 1862-1783
- OpenAlex
- W3143515426
- Cited by
- 177
- References
- 286
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.